Literature DB >> 16048989

Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing.

Harald Noedl1, Jan Bronnert, Kritsanai Yingyuen, Bernhard Attlmayr, Herwig Kollaritsch, Mark Fukuda.   

Abstract

A simple double-site sandwich enzyme-linked immunosorbent assay (ELISA) for Plasmodium falciparum in vitro drug sensitivity tests based on measuring histidine-rich protein 2 (HRP2) is presented. The ELISA uses two commercial monoclonal antibodies and provides a drastically cheaper alternative to the test kits previously used in the HRP2 drug sensitivity test. The assay is simple to establish and perform. The sensitivity is comparable and the drug sensitivity results very closely match those obtained with the commercial ELISA kits (R(2) = 0.979; P < 0.001; mean log difference at the 50% inhibitory concentration = 0.07).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16048989      PMCID: PMC1196223          DOI: 10.1128/AAC.49.8.3575-3577.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Histidine-rich protein II: a novel approach to malaria drug sensitivity testing.

Authors:  Harald Noedl; Walther H Wernsdorfer; Robert Scott Miller; Chansuda Wongsrichanalai
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  A histidine-rich protein 2-based malaria drug sensitivity assay for field use.

Authors:  Harald Noedl; Bernhard Attlmayr; Walther H Wernsdorfer; Herwig Kollaritsch; Robert S Miller
Journal:  Am J Trop Med Hyg       Date:  2004-12       Impact factor: 2.345

3.  Semi-quantitative measurement of Plasmodium falciparum antigen PfHRP2 in blood and plasma.

Authors:  V Desakorn; K Silamut; B Angus; D Sahassananda; K Chotivanich; P Suntharasamai; J Simpson; N J White
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Jul-Aug       Impact factor: 2.184

4.  A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay.

Authors:  P Druilhe; A Moreno; C Blanc; P H Brasseur; P Jacquier
Journal:  Am J Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.345

5.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique.

Authors:  R E Desjardins; C J Canfield; J D Haynes; J D Chulay
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

6.  Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method.

Authors:  H K Webster; E F Boudreau; K Pavanand; K Yongvanitchit; L W Pang
Journal:  Am J Trop Med Hyg       Date:  1985-03       Impact factor: 2.345

  6 in total
  65 in total

1.  Diagnostic potential of monoclonal antibodies developed against C-terminal polypeptide of P. falciparum Histidine Rich Protein2 (PfHRP2) in malaria infected patients from India.

Authors:  Reena Verma; Sara Chandy; N S Jayaprakash; Anand Manoharan; M A Vijayalakshmi; Krishnan Venkataraman
Journal:  Pathog Glob Health       Date:  2017-08-04       Impact factor: 2.894

2.  In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome.

Authors:  Harald Noedl; Srivicha Krudsood; Wattana Leowattana; Noppadon Tangpukdee; Wipa Thanachartwet; Sornchai Looareesuwan; Robert Scott Miller; Mark Fukuda; Krisada Jongsakul; Kritsanai Yingyuen; Sabaithip Sriwichai; Colin Ohrt; Charles Knirsch
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

3.  [In vitro antimalarial drug resistance in Southeastern Bangladesh].

Authors:  Bernhard Attlmayr; Kamala Thriemer; Rashidul Haque; Yukiko Wagatsuma; Mohammed Abdus Salam; Selim Akhter; Mark Fukuda; Kurt Schaecher; Robert Scott Miller; Harald Noedl
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

4.  Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.

Authors:  Jacob D Johnson; Richard A Dennull; Lucia Gerena; Miriam Lopez-Sanchez; Norma E Roncal; Norman C Waters
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

5.  Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.

Authors:  David J Bacon; Christine Latour; Carmen Lucas; Olga Colina; Pascal Ringwald; Stéphane Picot
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

6.  Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro.

Authors:  Lais Pessanha de Carvalho; Thaisa Lucas Sandri; Edésio José Tenório de Melo; Rolf Fendel; Peter G Kremsner; Benjamin Mordmüller; Jana Held
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

7.  Plasmodium falciparum: development of a transgenic line for screening antimalarials using firefly luciferase as the reporter.

Authors:  Long Cui; Jun Miao; Jiaxu Wang; Qianjun Li; Liwang Cui
Journal:  Exp Parasitol       Date:  2008-05-29       Impact factor: 2.011

Review 8.  Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers.

Authors:  Johannes Mischlinger; Caroline Rönnberg; Míriam J Álvarez-Martínez; Silja Bühler; Małgorzata Paul; Patricia Schlagenhauf; Eskild Petersen; Michael Ramharter
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

9.  Parasite burden and severity of malaria in Tanzanian children.

Authors:  Bronner P Gonçalves; Chiung-Yu Huang; Robert Morrison; Sarah Holte; Edward Kabyemela; D Rebecca Prevots; Michal Fried; Patrick E Duffy
Journal:  N Engl J Med       Date:  2014-05-08       Impact factor: 91.245

10.  Selection of a trioxaquine as an antimalarial drug candidate.

Authors:  Frédéric Coslédan; Laurent Fraisse; Alain Pellet; François Guillou; Benjamin Mordmüller; Peter G Kremsner; Alicia Moreno; Dominique Mazier; Jean-Pierre Maffrand; Bernard Meunier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.